Arvinas (ARVN) Price to FCF (2018 - 2026)
Powered by 
Analysis
Arvinas (ARVN) Price to FCF (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 10 | Arvinas | 608.15 Mn | 40.25 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.19 |
| Mar 31, 2026 | -9.70 |
| Dec 31, 2025 | -24.61 |
| Sep 30, 2025 | -10.19 |
| Jun 30, 2025 | -5.58 |
| Mar 31, 2025 | -5.74 |
| Dec 31, 2024 | -15.63 |
| Sep 30, 2024 | -13.15 |
| Jun 30, 2024 | 36.82 |
| Mar 31, 2024 | -28.89 |
| Dec 31, 2023 | -27.46 |
| Sep 30, 2023 | -12.58 |
| Jun 30, 2023 | -14.84 |
| Mar 31, 2023 | -15.81 |
| Dec 31, 2022 | -25.17 |
| Sep 30, 2022 | -34.40 |
| Jun 30, 2022 | -27.99 |
| Mar 31, 2022 | -60.37 |
| Dec 31, 2021 | -115.78 |
| Sep 30, 2021 | 6.38 |